Friedl-Naderer Johanna 4
4 · Vir Biotechnology, Inc. · Filed Mar 8, 2022
Insider Transaction Report
Form 4
Friedl-Naderer Johanna
Chief Business Officer, Global
Transactions
- Award
Common Stock
2022-03-02+90,000→ 90,000 total - Award
Stock Option (Right to Buy)
2022-03-02+45,000→ 45,000 totalExercise: $24.13Exp: 2032-03-01→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on March 2, 2023, and the remainder vest in 36 equal monthly installments thereafter.